MYT NETHERLANDS PARENT BV (MYTE) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:MYTE - US55406W1036 - ADR

7.64 USD

-0.2 (-2.55%)

Last: 4/30/2025, 8:23:38 PM

Fundamental Rating

MYTE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 122 industry peers in the Specialty Retail industry. MYTE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MYTE has a decent growth rate and is not valued too expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year MYTE was profitable.
MYTE had a negative operating cash flow in the past year.
MYTE had negative earnings in 4 of the past 5 years.
In multiple years MYTE reported negative operating cash flow during the last 5 years.

1.2 Ratios

MYTE has a Return On Assets of -5.01%. This is in the lower half of the industry: MYTE underperforms 68.85% of its industry peers.
Looking at the Return On Equity, with a value of -8.64%, MYTE is in line with its industry, outperforming 42.62% of the companies in the same industry.
MYTE has a Return On Invested Capital of 0.05%. This is in the lower half of the industry: MYTE underperforms 63.93% of its industry peers.

		Industry Rank	Sector Rank
ROA	-5.01%
ROE	-8.64%
ROIC	0.05%

ROA(3y)-2.35%

ROA(5y)-2.32%

ROE(3y)-3.64%

ROE(5y)-1.89%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Operating Margin of MYTE (0.03%) is worse than 63.93% of its industry peers.
Looking at the Gross Margin, with a value of 47.04%, MYTE is in the better half of the industry, outperforming 72.13% of the companies in the same industry.
In the last couple of years the Gross Margin of MYTE has remained more or less at the same level.

		Industry Rank	Sector Rank
OM	0.03%
PM (TTM)	N/A
GM	47.04%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.26%

GM growth 5Y-0.15%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

MYTE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for MYTE has been increased compared to 1 year ago.
Compared to 5 years ago, MYTE has less shares outstanding
Compared to 1 year ago, MYTE has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 4.23 indicates that MYTE is not in any danger for bankruptcy at the moment.
MYTE has a better Altman-Z score (4.23) than 86.07% of its industry peers.
MYTE has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
MYTE's Debt to Equity ratio of 0.19 is fine compared to the rest of the industry. MYTE outperforms 61.48% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.19
Debt/FCF	N/A
Altman-Z	4.23

ROIC/WACC0.01

WACC7.41%

2.3 Liquidity

A Current Ratio of 1.78 indicates that MYTE should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.78, MYTE is in the better half of the industry, outperforming 76.23% of the companies in the same industry.
MYTE has a Quick Ratio of 1.78. This is a bad value and indicates that MYTE is not financially healthy enough and could expect problems in meeting its short term obligations.
MYTE has a Quick ratio of 0.22. This is amonst the worse of the industry: MYTE underperforms 85.25% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.78
Quick Ratio	0.22

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

MYTE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 525.00%, which is quite impressive.
Looking at the last year, MYTE shows a quite strong growth in Revenue. The Revenue has grown by 11.84% in the last year.
MYTE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.27% yearly.

EPS 1Y (TTM)525%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%200%

Revenue 1Y (TTM)11.84%

Revenue growth 3Y11.16%

Revenue growth 5Y17.27%

Sales Q2Q%13.17%

3.2 Future

MYTE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 54.63% yearly.
Based on estimates for the next years, MYTE will show a quite strong growth in Revenue. The Revenue will grow by 9.58% on average per year.

EPS Next Y291%

EPS Next 2Y115.23%

EPS Next 3Y54.63%

EPS Next 5YN/A

Revenue Next Year9.06%

Revenue Next 2Y9.71%

Revenue Next 3Y9.58%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 27.29, MYTE can be considered very expensive at the moment.
MYTE's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 28.60. MYTE is around the same levels.
Based on the Price/Forward Earnings ratio of 18.32, the valuation of MYTE can be described as rather expensive.
Based on the Price/Forward Earnings ratio, MYTE is valued a bit cheaper than 61.48% of the companies in the same industry.
MYTE's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.83.

		Industry Rank	Sector Rank
PE	27.29
Fwd PE	18.32

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MYTE is valued a bit more expensive than 67.21% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	49.69

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MYTE's earnings are expected to grow with 54.63% in the coming years.